Cargando…

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options

BACKGROUND: Stemness refers to the capacities of self-renewal and repopulation, which contributes to the progression, relapse, and drug resistance of colorectal cancer (CRC). Mounting evidence has established the links between cancer stemness and intratumoral heterogeneity across cancer. Currently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zaoqu, Xu, Hui, Weng, Siyuan, Ren, Yuqing, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828967/ https://www.ncbi.nlm.nih.gov/pubmed/35154148 http://dx.doi.org/10.3389/fimmu.2022.828330

Ejemplares similares

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
por: Liu, Zaoqu, et al.
Publicado: (2022)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer
por: Xu, Hui, et al.
Publicado: (2023)

A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy
por: Jiang, Aimin, et al.
Publicado: (2022)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
por: Liu, Zaoqu, et al.
Publicado: (2022)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
por: Guo, Chunguang, et al.
Publicado: (2022)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

Gene interaction perturbation network deciphers a high-resolution taxonomy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
por: Jiang, Yafei, et al.
Publicado: (2022)

Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis
por: Yang, Bing, et al.
Publicado: (2021)

Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
por: Chen, Xingyu, et al.
Publicado: (2021)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy
por: Zhou, Peng, et al.
Publicado: (2022)

Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration
por: Jiang, Xiu-Feng, et al.
Publicado: (2022)

Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis
por: Xu, Hui, et al.
Publicado: (2022)

Multi-Omics Approaches in Immunological Research
por: Chu, Xiaojing, et al.
Publicado: (2021)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
por: Jiang, Yuxiong, et al.
Publicado: (2022)

Colorectal Cancer Immunotherapy: Options and Strategies
por: Johdi, Nor Adzimah, et al.
Publicado: (2020)

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Osteosarcoma Multi-Omics Landscape and Subtypes
por: Tang, Shan, et al.
Publicado: (2023)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

A unique regulated cell death-related classification regarding prognosis and immune landscapes in non-small cell lung cancer
por: Su, Wei, et al.
Publicado: (2023)

Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
por: Wu, Qinglong, et al.
Publicado: (2022)

The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients
por: Guo, Shiwei, et al.
Publicado: (2021)

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023)

Advances in the multi-omics landscape of follicular lymphoma
por: Xu, Tianyuan, et al.
Publicado: (2023)

Integrative bioinformatics analysis to explore a robust diagnostic signature and landscape of immune cell infiltration in sarcoidosis
por: Duo, Mengjie, et al.
Publicado: (2022)

“Multi-Omics” Analyses of the Development and Function of Natural Killer Cells
por: Zhou, Yonggang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_igekujbqj292e2ocpl2k3chupc